[go: up one dir, main page]

WO2002002579A3 - Haplotypes du gene eno3 - Google Patents

Haplotypes du gene eno3 Download PDF

Info

Publication number
WO2002002579A3
WO2002002579A3 PCT/US2001/020952 US0120952W WO0202579A3 WO 2002002579 A3 WO2002002579 A3 WO 2002002579A3 US 0120952 W US0120952 W US 0120952W WO 0202579 A3 WO0202579 A3 WO 0202579A3
Authority
WO
WIPO (PCT)
Prior art keywords
haplotypes
eno3
gene
disclosed
eno3 gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/020952
Other languages
English (en)
Other versions
WO2002002579A2 (fr
Inventor
Amy Duda
Kevin Finkel
Beena Koshy
Katie E Parks
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cogenics Inc
Original Assignee
Genaissance Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals Inc filed Critical Genaissance Pharmaceuticals Inc
Priority to AU2001270276A priority Critical patent/AU2001270276A1/en
Publication of WO2002002579A2 publication Critical patent/WO2002002579A2/fr
Publication of WO2002002579A3 publication Critical patent/WO2002002579A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne de nouvelles variantes génétiques du gène (ENO3) enolase 3, (bêta enolase spécifique du muscle). Cette invention concerne également divers génotypes, haplotypes, et paires d'haplotypes du gène ENO3, existant dans la population générale des Etats-Unis. Par ailleurs, cette invention concerne des compositions et des méthodes d'haplotypage et/ou de génotypage du gène ENO3 chez un individu. Enfin, l'invention concerne des polynucléotides définis par les haplotypes précités.
PCT/US2001/020952 2000-06-30 2001-07-02 Haplotypes du gene eno3 Ceased WO2002002579A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001270276A AU2001270276A1 (en) 2000-06-30 2001-07-02 Haplotypes of the eno3 gene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21523600P 2000-06-30 2000-06-30
US60/215,236 2000-06-30

Publications (2)

Publication Number Publication Date
WO2002002579A2 WO2002002579A2 (fr) 2002-01-10
WO2002002579A3 true WO2002002579A3 (fr) 2002-08-08

Family

ID=22802198

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/020952 Ceased WO2002002579A2 (fr) 2000-06-30 2001-07-02 Haplotypes du gene eno3

Country Status (2)

Country Link
AU (1) AU2001270276A1 (fr)
WO (1) WO2002002579A2 (fr)

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CALI ET AL.: "Nucleotide sequence of a cDNA encoding the human muscle-specific enolase (MSE)", NUCLEIC ACIDS RESEARCH, vol. 18, no. 7, 1990, pages 1893, XP002950389 *
DATABASE GENBANK [online] June 1997 (1997-06-01), FEO, S., XP002950388, accession no. NCBI Database accession no. (X56832) *
DATABASE SNP [online] NATIONAL LIBRARY OF MEDICINE, NIH (BETHESDA, MD, USA); September 2000 (2000-09-01), XP002951614, retrieved from rs1133199 accession no. NCBI Database accession no. (SS1532006) *
EUR. J. BIOCHEM., vol. 214, no. 2, 1993, pages 367 - 374 *

Also Published As

Publication number Publication date
AU2001270276A1 (en) 2002-01-14
WO2002002579A2 (fr) 2002-01-10

Similar Documents

Publication Publication Date Title
WO2002010454A3 (fr) Haplotypes du gene alas2? ¿
WO2002002579A3 (fr) Haplotypes du gene eno3
WO2001077363A3 (fr) Haplotypes du gene impdh2
WO2002090512A3 (fr) Haplotypes du gene nnmt
WO2002002580A3 (fr) Haplotypes du gene etfb
WO2002012499A3 (fr) Haplotypes du gene ntf3
WO2002050098A3 (fr) Haplotypes du gene du recepteur de la prolactine (prlr)
WO2002040502A3 (fr) Haplotypes du gene de la lipase hormono-sensible
WO2001092278A3 (fr) Haplotypes du gene rlbp1
WO2001094362A3 (fr) Haplotypes du gene acp2
WO2002030950A3 (fr) Haplotypes du gene fy
WO2001087909A3 (fr) Haplotypes du gene aanat
WO2001090118A3 (fr) Haplotypes du gene edn2
WO2001090126A3 (fr) Haplotypes du gene snap29
WO2002038586A3 (fr) Haplotypes du gene il6
WO2001090119A3 (fr) Haplotypes du gene aldh5a1
WO2002016399A3 (fr) Haplotypes du gene tacr1
WO2002026766A3 (fr) Haplotypes du gene sstr4
WO2002090378A3 (fr) Haplotypes du gene de ces2
WO2001087907A3 (fr) Haplotypes du gene de l'osm
WO2002020556A3 (fr) Haplotypes du gene gpr68
WO2001090128A3 (fr) Haplotypes du gene gpr3
WO2002032930A3 (fr) Haplotypes du gene scya21
WO2001092279A3 (fr) Haplotypes du gene aldh5
WO2002032924A3 (fr) Haplotypes du gene chrm5

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP